Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case–control study

K Wierckx, E Elaut, E Declercq… - European journal of …, 2013 - academic.oup.com
Objective This study evaluated the short-and long-term cardiovascular-and cancer-related
morbidities during cross-sex hormone therapy in a large sample of trans persons. Subjects …

Male breast disease: pictorial review with radiologic-pathologic correlation

C Nguyen, MD Kettler, ME Swirsky, VI Miller, C Scott… - Radiographics, 2013 - pubs.rsna.org
The male breast is susceptible to many of the same pathologic processes as the female
breast. Many of these conditions have mammographic, ultrasonographic (US), and magnetic …

Management of transgenderism

NP Spack - Jama, 2013 - jamanetwork.com
Gender identity disorder (transgenderism) is poorly understood from both mechanistic and
clinical standpoints. Awareness of the condition appears to be increasing, probably because …

[HTML][HTML] Exploration of functional health, mental well-being and cross-sex hormone use in a sample of Thai male-to-female transgendered persons (kathoeys)

LJ Gooren, T Sungkaew, EJ Giltay - Asian Journal of Andrology, 2013 - ncbi.nlm.nih.gov
Transgender people sometimes use cross-sex hormones without medical supervision. The
use of cross-sex hormones, as well as the functional health and mental well-being, among …

Risks and benefits of estrogen therapy for a male-to-female transsexual with a prothrombin gene mutation

E Laidlaw, MS Irwig - Endocrine Practice, 2013 - Elsevier
Objective We present the case of a male-to-female transsexual person in her 20s requesting
hormone therapy in the setting of a history of a deep venous thrombosis and pulmonary …

Sex reassignment: Endocrinological interventions in adults with gender dysphoria

L Gooren, H Asscheman - Gender dysphoria and disorders of sex …, 2013 - Springer
Transgender people may wish to transition to the other sex, usually to the fullest extent
possible. Part of that transition is enabled by the administration of cross-sex hormones and …

[PDF][PDF] Hormonal contraceptives and venous thrombosis

BHB Stegeman - Department of Thrombosis and …, 2013 - scholarlypublications …
In 1960, shortly after the introduction of combined oral contraceptive Enovid®(150 µg
mestranol, an estrogen, and 985 mg norethynodrel, a progestagen), the first case of venous …